Medicine
Foreign acquirers reshape Vietnam pharma manufacturers: 2023–2026 deal review
Livzon's 64.81% takeover of Imexpharm is the largest deal in a longer foreign-acquisition cycle that also touches Dược Hậu Giang, Domesco, Pymepharco, Traphaco, Dược Hà Tây, and Trung Sơn Pharma — shaped by EU-GMP capacity, hospital-tender economics, and Vietnam's foreign-distribution rules.